Setting the Record Straight Several brands have launched public campaigns implying compounded GLP-1 medications are counterfeit, unsafe, or illegitimate. These accusations are false, misleading, and harmful to patient care
It is important to consult a healthcare professional before starting any new supplement regimen
If you quit after three days because nothing happened, you never gave the peptide a chance to do its work
If these drugs become more available, were going to change the face of society because were going to stop the obesity epidemic.
Amgens monthly maridebart cafraglutide and Novo Nordisks fixed-dose CagriSema combination target superior efficacy without added injection frequency, signaling competitive dimensions will increasingly pivot on dosing simplicity and multi-pathway synergy
Factors Consumers Often Consider When Evaluating Telehealth GLP-1 Platforms Rather than presenting a subjective assessment, this section outlines the factors that publicly available consumer guidance and healthcare resources suggest are worth considering when evaluating any telehealth GLP-1 program